Search Results

Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD

Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD

Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) | Kosh Agarwal, MD

Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) | Kosh Agarwal, MD

Capsid Assembly Modulators CAMs - Adam Zlotnick

Capsid Assembly Modulators CAMs - Adam Zlotnick

Virological Approach - New Nucleoside Analogue & Capsid inhibition | Fabien Zoulim, MD, PhD

Virological Approach - New Nucleoside Analogue & Capsid inhibition | Fabien Zoulim, MD, PhD

CCC – DNA inhibition | Anuj Gaggar, MD, PhD

CCC – DNA inhibition | Anuj Gaggar, MD, PhD

How to Handle Flares in HBV Trials With Novel Agents - H. Janssen, MD, PhD

How to Handle Flares in HBV Trials With Novel Agents - H. Janssen, MD, PhD

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

Hepatitis B Cure

Hepatitis B Cure

Use of PARP1-selective and ATR inhibitors to target DDR signalling pathway

Use of PARP1-selective and ATR inhibitors to target DDR signalling pathway

HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.

HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.

Hepatitis B Virus | Hepatitis B virology | Hepatitis B replication | Hepatitis B virus microbiology

Hepatitis B Virus | Hepatitis B virology | Hepatitis B replication | Hepatitis B virus microbiology

ICE-HBV Cure Symposium 2021 - Combinations of direct acting antivirals to decrease the cccDNA pool

ICE-HBV Cure Symposium 2021 - Combinations of direct acting antivirals to decrease the cccDNA pool